Cargando…
2021 marks a new era for Alzheimer's therapeutics
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687665/ https://www.ncbi.nlm.nih.gov/pubmed/34942134 http://dx.doi.org/10.1016/S1474-4422(21)00412-9 |
| _version_ | 1784618219351310336 |
|---|---|
| author | Kantarci, Kejal |
| author_facet | Kantarci, Kejal |
| author_sort | Kantarci, Kejal |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8687665 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86876652021-12-21 2021 marks a new era for Alzheimer's therapeutics Kantarci, Kejal Lancet Neurol 2021 Round-up Elsevier Ltd. 2022-01 2021-12-20 /pmc/articles/PMC8687665/ /pubmed/34942134 http://dx.doi.org/10.1016/S1474-4422(21)00412-9 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | 2021 Round-up Kantarci, Kejal 2021 marks a new era for Alzheimer's therapeutics |
| title | 2021 marks a new era for Alzheimer's therapeutics |
| title_full | 2021 marks a new era for Alzheimer's therapeutics |
| title_fullStr | 2021 marks a new era for Alzheimer's therapeutics |
| title_full_unstemmed | 2021 marks a new era for Alzheimer's therapeutics |
| title_short | 2021 marks a new era for Alzheimer's therapeutics |
| title_sort | 2021 marks a new era for alzheimer's therapeutics |
| topic | 2021 Round-up |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687665/ https://www.ncbi.nlm.nih.gov/pubmed/34942134 http://dx.doi.org/10.1016/S1474-4422(21)00412-9 |
| work_keys_str_mv | AT kantarcikejal 2021marksaneweraforalzheimerstherapeutics |